Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

307 Articles

Jon C. Ogg | Dec 18, 2017 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: AMD, Amazon, Capital One, Costco, Delphi, Twitter and Many More

The top analyst upgrades, downgrades and other research calls from Monday include Advanced Micro Devices, Amazon.com, Capital One, Costco, Delphi…

Chris Lange | Dec 12, 2017 at 10:10 AM EST

Major Biotechs See Rising Tide in Short Interest

The November 30 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Dec 8, 2017 at 9:40 AM EST

Will Alexion Pharmaceuticals Fight This Activist?

Alexion Pharmaceuticals shares saw a handy gain early on Friday after the New York Times reported that there might be…

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

Chris Lange | Nov 10, 2017 at 10:40 AM EST

Short Sellers Grow More Selective on Major Biotechs

The October 31 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Oct 25, 2017 at 10:40 AM EDT

Short Sellers Chase Biotechs Higher

The October 13 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Chris Lange | Oct 11, 2017 at 11:35 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech…

Lee Jackson | Oct 6, 2017 at 10:25 AM EDT

4 Biotech Stocks to Buy That May See Huge Volatility From Earnings

Some of the top biotech stocks could become extremely volatile before and after earnings. These four that may be worth…

Chris Lange | Sep 30, 2017 at 8:20 AM EDT

Major Biotech, Pharma and FDA Catalysts Coming in October

24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.

Chris Lange | Sep 27, 2017 at 10:25 AM EDT

Short Sellers Hike Bets in Major Biotechs

The September 15 short interest data have been compared with the previous report, and short interest in all the selected…

Chris Lange | Sep 13, 2017 at 8:55 AM EDT

Short Sellers Hike Bets in Major Biotechs

The August 31 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Sep 5, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Chesapeake Energy, Lululemon, Oracle, US Steel, Disney, YogaWorks and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Chesapeake Energy, Lululemon Athletica, Oracle, US Steel, Walt…

Chris Lange | Aug 25, 2017 at 10:10 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Aug 10, 2017 at 8:50 AM EDT

Major Biotechs Send Short Sellers Running for Cover

The July 31 short interest data have been compared with the previous report, and short interest in most of the…

1 … 7 8 9 10 11 … 21

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

Top Analyst Upgrades and Downgrades: AMD, Amazon, Capital One, Costco, Delphi, Twitter and Many More

Major Biotechs See Rising Tide in Short Interest

Will Alexion Pharmaceuticals Fight This Activist?

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Chase Biotechs Higher

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Short Sellers Grow More Selective on Major Biotechs

4 Biotech Stocks to Buy That May See Huge Volatility From Earnings

Major Biotech, Pharma and FDA Catalysts Coming in October

Short Sellers Hike Bets in Major Biotechs

Short Sellers Hike Bets in Major Biotechs

Top Analyst Upgrades and Downgrades: Chesapeake Energy, Lululemon, Oracle, US Steel, Disney, YogaWorks and More

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Major Biotechs Send Short Sellers Running for Cover

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

Top Analyst Upgrades and Downgrades: AMD, Amazon, Capital One, Costco, Delphi, Twitter and Many More

Major Biotechs See Rising Tide in Short Interest

Will Alexion Pharmaceuticals Fight This Activist?

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Chase Biotechs Higher

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Short Sellers Grow More Selective on Major Biotechs

4 Biotech Stocks to Buy That May See Huge Volatility From Earnings

Major Biotech, Pharma and FDA Catalysts Coming in October

Short Sellers Hike Bets in Major Biotechs

Short Sellers Hike Bets in Major Biotechs

Top Analyst Upgrades and Downgrades: Chesapeake Energy, Lululemon, Oracle, US Steel, Disney, YogaWorks and More

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Major Biotechs Send Short Sellers Running for Cover

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do